Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “TAM”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03381963
What this trial is testing

Hemostatic Profiles of Endocrine Therapies for Breast Cancer

Who this might be right for
Breast NeoplasmsVenous Thromboembolism
University Hospital, Geneva 100
Large-scale testing (Phase 3)Study completedNCT00322101
What this trial is testing

Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAcute Myeloid Leukemia/Transient Myeloproliferative DisorderAdult Acute Myeloid Leukemia in Remission+16 more
Fred Hutchinson Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT02517593
What this trial is testing

Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake

Who this might be right for
Breast Cancer
Mayo Clinic 151
Not applicableStudy completedNCT04479098
What this trial is testing

Effects of Training and Detraining on Postmenopausal Breast Cancer Survivors

Who this might be right for
Breast Neoplasm Female
Federal University of Uberlandia 14
Large-scale testing (Phase 3)Study completedNCT00171704
What this trial is testing

Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer

Who this might be right for
Hormone Sensitive Resected Primary Breast Cancer in Postmenopausal Women
Novartis Pharmaceuticals 263
Testing effectiveness (Phase 2)UnknownNCT00024336
What this trial is testing

Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Cancer and Leukaemia Group
Early research (Phase 1)Study completedNCT01164163
What this trial is testing

INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+2 more
Children's Oncology Group 49
Large-scale testing (Phase 3)UnknownNCT00541086
What this trial is testing

Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery

Who this might be right for
Breast Cancer
Gruppo Italiano Mammella (GIM) 3,697
Testing effectiveness (Phase 2)Ended earlyNCT02395627
What this trial is testing

Reversing Therapy Resistance With Epigenetic-Immune Modification

Who this might be right for
Breast Neoplasms
University of California, San Francisco 38
Large-scale testing (Phase 3)UnknownNCT03351062
What this trial is testing

Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

Who this might be right for
Breast Cancer Female
Chinese Anti-Cancer Association 844
Large-scale testing (Phase 3)Study completedNCT00072462
What this trial is testing

Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ

Who this might be right for
Breast Cancer
Queen Mary University of London 2,980
Testing effectiveness (Phase 2)Study completedNCT03045653
What this trial is testing

Efficacy of High Dose Tamoxifen to Advanced Hormone Receptor-High Expressed Breast Cancer

Who this might be right for
Breast Cancer Metastatic
Sun Yat-sen University 30
Not applicableUnknownNCT05801705
What this trial is testing

Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study

Who this might be right for
Hormone-receptor-positive Breast CancerPremenopausal Breast CancerBreast Cancer Patients at Intermediate to High Risk+1 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 700
Not applicableStudy completedNCT00965939
What this trial is testing

An Observational Study to Assess Response to Tamoxifen in Breast Cancer Patients

Who this might be right for
ER-positive Breast Cancer
Vlaamse Vereniging voor Obstetrie en Gynaecologie 300
Not applicableStudy completedNCT03554668
What this trial is testing

Systemic Inflammatory Response: Thiamine and Magnesium Status (Sir TaM Study)

Who this might be right for
InflammationMagnesium DeficiencyIron-deficiency+1 more
Glasgow Royal Infirmary 47
Large-scale testing (Phase 3)Study completedNCT00929591
What this trial is testing

SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer

Who this might be right for
Breast Cancer
SWOG Cancer Research Network 1,558
Large-scale testing (Phase 3)Study completedNCT00002579
What this trial is testing

Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer

Who this might be right for
Breast Cancer
Scottish Cancer Therapy Network 2,000
Testing effectiveness (Phase 2)UnknownNCT00305838
What this trial is testing

CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Mount Vernon Cancer Centre at Mount Vernon Hospital 200
Early research (Phase 1)Study completedNCT00749138
What this trial is testing

Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy

Who this might be right for
Chronic Hepatitis C
Bader, Ted, M.D. 18
Large-scale testing (Phase 3)UnknownNCT00002460
What this trial is testing

Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer

Who this might be right for
Breast Cancer
Cancer Research UK
Next Page